Evidence has recently accumulated showing that antiidiotypic antibodies spe
cific to anti-FVIII antibodies are present in the plasma of healthy individ
uals and of haemophilia A patients with or without inhibitors, where they c
an neutralise the FVIII inhibitory activity, Additionally, patients success
fully desensitised towards FVIII have an increased production of anti-idiot
ypic antibodies with no significant reduction in anti-FVIII antibodies. We
review here possible strategies for modulating the anti-FVIII immune respon
se by idiotypic interactions.